Safety and Efficacy of the Minimally Invasive Bentall Procedure Via a Small Right Intercostal Incision in Patients With Aortic Root Lesions
Launched by FIRST AFFILIATED HOSPITAL XI'AN JIAOTONG UNIVERSITY · Dec 11, 2023
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a surgical procedure called the Bentall procedure, which is used to treat issues with the aortic root, such as aortic dissection and aortic root aneurysm. The trial is comparing two different ways of performing this surgery: one method uses a small incision on the right side of the chest (minimally invasive), and the other uses a larger incision down the middle of the chest (traditional). The goal is to find out which method is safer and more effective for patients who need this type of surgery.
To participate in this trial, patients need to be diagnosed with aortic root lesions and have received the Bentall procedure at the First Affiliated Hospital of Xi'an Jiaotong University between January 2019 and July 2023. However, some patients may not be eligible, such as those who have had previous heart surgeries or have serious health conditions affecting other organs. Participants in the trial can expect to have their medical data compared between the two surgical methods to help researchers understand the best approach for treating their condition. This information could lead to better treatment options for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Patients who were diagnosed with aortic root lesions and treated with the Bentall procedure at the First Affiliated Hospital of Xi'an Jiaotong University from January 2019 to July 2023 will be included in this study.
- Exclusion Criteria:
- • Previous sternotomy or aortic root surgery;
- • Combined coronary artery disease requiring simultaneous coronary revascularization;
- • Combined aortic arch lesions requiring simultaneous aortic arch surgery;
- • Preoperative comorbidities with severe single or multiple organ failure;
- • Incomplete clinical information;
About First Affiliated Hospital Xi'an Jiaotong University
The First Affiliated Hospital of Xi'an Jiaotong University is a leading medical institution renowned for its commitment to advancing healthcare through clinical research and innovative treatment approaches. As a prominent academic hospital in China, it integrates clinical practice, education, and research, fostering a collaborative environment that enables the development of cutting-edge therapies and medical technologies. With a multidisciplinary team of experts and state-of-the-art facilities, the hospital plays a pivotal role in conducting high-quality clinical trials that aim to improve patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Xi'an, Shaanxi, China
Patients applied
Trial Officials
Yang Yan
Principal Investigator
First Affiliated Hospital Xi'an Jiaotong University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported